Cryptosporidium infection in solid organ transplantation

Area of Science:

• Infectious diseases
• Transplant medicine
• Parasitology

Background:

• Diarrhea is a frequent complication in solid organ transplant (SOT) recipients.
• Infections, including Cryptosporidium, are common causes of diarrhea in SOT patients.
• Cryptosporidium, typically causing self-limited diarrhea in healthy individuals, can lead to severe, protracted illness in SOT recipients.

Purpose of the Study:

• To review the epidemiology, diagnosis, and management of Cryptosporidium infections in SOT recipients.
• To highlight the under-recognized burden of Cryptosporidium-related diarrhea in this vulnerable population.
• To discuss current and future therapeutic strategies for cryptosporidiosis in SOT patients.

Main Methods:

• Literature review focusing on epidemiological data, diagnostic advancements, and treatment outcomes.
• Analysis of studies pertaining to Cryptosporidium infections in solid organ transplant recipients.
• Synthesis of information on clinical presentation, diagnostic tools, and therapeutic interventions.

Main Results:

• Cryptosporidium is an under-recognized cause of infectious diarrhea in SOT recipients, potentially leading to severe outcomes like organ failure.
• Diagnostic methods for Cryptosporidium have improved, enabling faster identification.
• Current treatments, including Nitazoxanide, offer modest efficacy, and management often involves supportive care and immunosuppression reduction.

Conclusions:

• Cryptosporidium poses a significant threat to SOT recipients, necessitating increased awareness and improved management strategies.
• Further development of antiparasitic drugs and vaccines is essential to combat cryptosporidiosis in this population.
• A comprehensive approach combining diagnostics, supportive care, and optimized therapeutic regimens is critical for SOT patients with Cryptosporidium infection.